Velpharma Holding ApS: Financial statements 2025
CVR: 43646273
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Velpharma Holding ApS (CVR 43646273) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,283 and a net result of DKK -2,283 compared with DKK -3,270 the year before. Equity in the 2025 report amounted to DKK 29,160. The solvency ratio was 69.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -2,283
- Profit/Loss
- DKK -2,283
- Equity
- DKK 29,160
- Total Assets
- DKK 41,818
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -2 t. | -2 t. | 29 t. | 0 |
| 2024 | - | -3 t. | -3 t. | 31 t. | 0 |
Official annual report
How creditworthy is Velpharma Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Velpharma Holding ApS has published its annual report for 2024. Gross profit came to DKK -3,270, and the net result was DKK -3,270.
About Velpharma Holding ApS
Velpharma Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Rasmus Blaabjerg Ahm Sørensen, Jacob Benné Arleth and Jannik Khirkhoff Jonsson. The company's owners include Søren Arleth, Rasmus Blaabjerg Ahm Sørensen and Jacob Benné Arleth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,283 and a net result of DKK -2,283 compared with DKK -3,270 the year before. Equity in the 2025 report amounted to DKK 29,160.